BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 27104682)

  • 21. Intrahepatic cholangiocarcinomas mimicking other lesions.
    Adam SZ; Parthasarathy S; Miller FH
    Abdom Imaging; 2015 Oct; 40(7):2345-54. PubMed ID: 26088342
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Imaging of peripheral cholangiocarcinoma. Comparison with pathological anatomy].
    Gautier AL; Vilgrain V; Fléjou JF; Valverde A; Belghiti J; Zins M; Nahum H; Menu Y
    Gastroenterol Clin Biol; 1996 Mar; 20(2):139-45. PubMed ID: 8761673
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Imaging Spectrum of Intrahepatic Mass-Forming Cholangiocarcinoma and Its Mimickers: How to Differentiate Them Using MRI.
    Kovač JD; Janković A; Đikić-Rom A; Grubor N; Antić A; Dugalić V
    Curr Oncol; 2022 Jan; 29(2):698-723. PubMed ID: 35200560
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dynamic enhancement patterns of small-diameter mass-forming intrahepatic cholangiocarcinomas on contrast-enhanced magnetic resonance imaging: Challenges faced by the radiologist.
    Liang W; Wan D; Lu Q; Lin S; Chen Z
    Medicine (Baltimore); 2017 Oct; 96(43):e8351. PubMed ID: 29069015
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intranodular signal intensity analysis of hypovascular high-risk borderline lesions of HCC that illustrate multi-step hepatocarcinogenesis within the nodule on Gd-EOB-DTPA-enhanced MRI.
    Kobayashi S; Matsui O; Gabata T; Koda W; Minami T; Ryu Y; Kozaka K; Kitao A
    Eur J Radiol; 2012 Dec; 81(12):3839-45. PubMed ID: 22884705
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dynamic MRI of solitary pulmonary nodules: comparison of enhancement patterns of malignant and benign small peripheral lung lesions.
    Kono R; Fujimoto K; Terasaki H; Müller NL; Kato S; Sadohara J; Hayabuchi N; Takamori S
    AJR Am J Roentgenol; 2007 Jan; 188(1):26-36. PubMed ID: 17179342
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The CT and MRI Features of Primary Intrahepatic Lymphoepithelioma-Like Cholangiocarcinoma.
    Yang Q; Cai Q; Wen H; Mao Y; Ban X; Rong D; Zhang R
    AJR Am J Roentgenol; 2021 Feb; 216(2):393-402. PubMed ID: 33325732
    [No Abstract]   [Full Text] [Related]  

  • 28. Intrahepatic mass-forming cholangiocarcinoma: enhancement pattern on Gd-BOPTA-MRI with emphasis of hepatobiliary phase.
    Mamone G; Marrone G; Caruso S; Carollo V; Gentile G; Crino' F; Milazzo M; Luca A
    Abdom Imaging; 2015 Oct; 40(7):2313-22. PubMed ID: 25962708
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differentiation of infiltrative cholangiocarcinoma from benign common bile duct stricture using three-dimensional dynamic contrast-enhanced MRI with MRCP.
    Yu XR; Huang WY; Zhang BY; Li HQ; Geng DY
    Clin Radiol; 2014 Jun; 69(6):567-73. PubMed ID: 24581958
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intrahepatic mass-forming cholangiocarcinoma: enhancement patterns on gadoxetic acid-enhanced MR images.
    Kang Y; Lee JM; Kim SH; Han JK; Choi BI
    Radiology; 2012 Sep; 264(3):751-60. PubMed ID: 22798225
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of focal liver lesions (FLL) with acoustic radiation force impulse (ARFI) elastometry.
    Heide R; Strobel D; Bernatik T; Goertz RS
    Ultraschall Med; 2010 Aug; 31(4):405-9. PubMed ID: 20652853
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intrahepatic peripheral cholangiocarcinoma in cirrhosis patients may display a vascular pattern similar to hepatocellular carcinoma on contrast-enhanced ultrasound.
    Vilana R; Forner A; Bianchi L; García-Criado A; Rimola J; de Lope CR; Reig M; Ayuso C; Brú C; Bruix J
    Hepatology; 2010 Jun; 51(6):2020-9. PubMed ID: 20512990
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of focal liver lesions: use of mangafodipir trisodium (MnDPDP)-enhanced MR images.
    Karabacakoğlu A; Adigüzel Y; Karaköse S; Kayaçetin E; Haykir R
    Turk J Gastroenterol; 2006 Sep; 17(3):164-71. PubMed ID: 16941248
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Malignant versus benign hepatic masses in patients with recurrent pyogenic cholangitis: MR differential diagnosis.
    Eun HW; Kim JH; Hong SS; Kim YJ
    Abdom Imaging; 2012 Oct; 37(5):767-74. PubMed ID: 22179742
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lesion discrimination with breath-hold hepatic diffusion-weighted imaging: a meta-analysis.
    Chen ZG; Xu L; Zhang SW; Huang Y; Pan RH
    World J Gastroenterol; 2015 Feb; 21(5):1621-7. PubMed ID: 25663782
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differentiation of extrahepatic bile duct cholangiocarcinoma from benign stricture: findings at MRCP versus ERCP.
    Park MS; Kim TK; Kim KW; Park SW; Lee JK; Kim JS; Lee JH; Kim KA; Kim AY; Kim PN; Lee MG; Ha HK
    Radiology; 2004 Oct; 233(1):234-40. PubMed ID: 15333766
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Dynamic MRI of the liver with parallel acquisition technique: characterization of focal liver lesions and analysis of the hepatic vasculature in a single MRI session].
    Heilmaier C; Sutter R; Lutz AM; Seifert B; Willmann JK
    Rofo; 2008 May; 180(5):440-8. PubMed ID: 18438745
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation of CT patterns of primary intrahepatic cholangiocarcinoma at the time of presentation with the metastatic spread and clinical outcomes: retrospective study of 92 patients.
    Baheti AD; Tirumani SH; Shinagare AB; Rosenthal MH; Hornick JL; Ramaiya NH; Wolpin BM
    Abdom Imaging; 2014 Dec; 39(6):1193-201. PubMed ID: 24869789
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dynamic contrast-enhanced ultrasound (DCE-US) for the characterization of hepatocellular carcinoma and cholangiocellular carcinoma.
    Wildner D; Pfeifer L; Goertz RS; Bernatik T; Sturm J; Neurath MF; Strobel D
    Ultraschall Med; 2014 Dec; 35(6):522-7. PubMed ID: 25202903
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intrahepatic cholangiocarcinomas in cirrhosis are hypervascular in comparison with those in normal livers.
    Xu J; Igarashi S; Sasaki M; Matsubara T; Yoneda N; Kozaka K; Ikeda H; Kim J; Yu E; Matsui O; Nakanuma Y
    Liver Int; 2012 Aug; 32(7):1156-64. PubMed ID: 22417172
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.